These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 32988822

  • 41. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
    Adembri C, Fallani S, Cassetta MI, Arrigucci S, Ottaviano A, Pecile P, Mazzei T, De Gaudio R, Novelli A.
    Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination.
    Cantoni L, Glauser MP, Bille J.
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2348-53. PubMed ID: 1965105
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Bone, subcutaneous tissue and plasma pharmacokinetics of cefuroxime in total knee replacement patients - a randomized controlled trial comparing continuous and short-term infusion.
    Tøttrup M, Søballe K, Bibby BM, Hardlei TF, Hansen P, Fuursted K, Birke-Sørensen H, Bue M.
    APMIS; 2019 Dec; 127(12):779-788. PubMed ID: 31515843
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial.
    Benítez-Cano A, Luque S, Sorlí L, Carazo J, Ramos I, Campillo N, Curull V, Sánchez-Font A, Vilaplana C, Horcajada JP, Adalia R, Bermejo S, Samsó E, Hope W, Grau S.
    Crit Care; 2020 Feb 17; 24(1):55. PubMed ID: 32066497
    [Abstract] [Full Text] [Related]

  • 50. Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae.
    Cojutti P, Sartor A, Righi E, Scarparo C, Bassetti M, Pea F.
    Antimicrob Agents Chemother; 2017 Oct 17; 61(10):. PubMed ID: 28760900
    [Abstract] [Full Text] [Related]

  • 51. Population Pharmacokinetic Analysis of Doripenem after Intravenous Infusion in Korean Patients with Acute Infections.
    Lee DH, Kim YK, Jin K, Kang MJ, Joo YD, Kim YW, Moon YS, Shin JG, Kiem S.
    Antimicrob Agents Chemother; 2017 May 17; 61(5):. PubMed ID: 28223378
    [Abstract] [Full Text] [Related]

  • 52. Piperacillin pharmacokinetics and target attainment in children with cancer and fever: Can we optimize our dosing strategy?
    Maarbjerg SF, Thorsted A, Kristoffersson A, Friberg LE, Nielsen EI, Wang M, Brock B, Schrøder H.
    Pediatr Blood Cancer; 2019 Jun 17; 66(6):e27654. PubMed ID: 30740885
    [Abstract] [Full Text] [Related]

  • 53. Optimal dosing regimen of biapenem in Chinese patients with lower respiratory tract infections based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation.
    Dong J, Xiong W, Chen Y, Zhao Y, Lu Y, Zhao D, Li W, Liu Y, Chen X.
    Int J Antimicrob Agents; 2016 Mar 17; 47(3):202-9. PubMed ID: 26895604
    [Abstract] [Full Text] [Related]

  • 54. Determining optimal dosing regimen of oral administration of dicloxacillin using Monte Carlo simulation.
    Yu W, Ji J, Xiao T, Ying C, Fang J, Shen P, Xiao Y.
    Drug Des Devel Ther; 2017 Mar 17; 11():1951-1956. PubMed ID: 28721014
    [Abstract] [Full Text] [Related]

  • 55. In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion.
    Yu Y, Zhou YF, Chen MR, Li X, Qiao GL, Sun J, Liao XP, Liu YH.
    PLoS One; 2016 Mar 17; 11(5):e0156273. PubMed ID: 27218674
    [Abstract] [Full Text] [Related]

  • 56. Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
    Rybak MJ, Houlihan HH, Mercier RC, Kaatz GW.
    Antimicrob Agents Chemother; 1997 Jun 17; 41(6):1359-63. PubMed ID: 9174199
    [Abstract] [Full Text] [Related]

  • 57. Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery.
    Lu C, Zhang Y, Chen M, Zhong P, Chen Y, Yu J, Wu X, Wu J, Zhang J.
    Antimicrob Agents Chemother; 2016 Nov 17; 60(11):6619-6625. PubMed ID: 27572392
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis.
    Fernández Guerrero ML, de Górgolas M.
    J Antimicrob Chemother; 2006 Nov 17; 58(5):1066-9. PubMed ID: 16931540
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.